
Loading summary
A
Support for this episode comes from Dexcom, A very smart doctor told us ages ago, probably close to 19 years ago, when Benny was first diagnosed with diabetes. The person with the most data wins along with the most data. You need good data and the Dexcom G7 CGM systems are the most accurate sensors on the market, and accuracy is what builds confidence. Benny can make decisions about food and activity in real time, and we can easily follow his numbers remotely. The Dexcom Clarity app shows glucose trends and even a projected A1C in as little as two weeks. This isn't just about seeing numbers, it's about understanding them and living better because of it. Find out more@dexcom.com. Hello and welcome to another week of Diabetes Connections. I am your host Steven Stacey Sims and this is an in the news episode where we bring you the top diabetes stories and headlines happening now. A reminder you can find the sources and links and a full transcript and more information for every story that is mentioned here. To do that, just head to the show Notes if you can't find them where you are listening. If you're listening on a podcast app, head on over to diabetes-connections.com and I know I say that every episode, but I am still meeting people here in the year 2026 who have never listened to a podcast. They find this show. It just happened to me the other night at the Club 1921 event in Atlanta. I am not shy. If someone tells me they don't know anything about a podcast, I'm gonna grab their phone and load it up. Because it's not just about this podcast. There's so many great diabetes podcasts, but there's great other podcasts. You know how I feel about this. Audio is the greatest medium and we are always getting new listeners. So head on over to the website to diabetes-connections.com for more on everything in this episode. A big thanks to everybody who did come to Atlanta for a SOL out a waitlisted club 1921. We are heading to our Philadelphia event in King of Prussia tomorrow on Wednesday. Can't wait to meet you all then. And please consider signing up for our Mom's Night out fall events pretty quickly. We have our early bird specials up for Detroit and Seattle right now. Detroit is in September, Seattle is in October. These are events for moms of kids with diabetes and for adult women with Type one. And the fall is going to be here before you know it, so please let us know if you are coming. All the event info is on the website as well. Okay, let's get to the news. Our top story this week Swedish researchers have developed an improved method for creating insulin producing cells from human stem cells. These cells effectively regulate blood sugar levels in lab tests and can reverse diabetes in mice. The optimized production process yields more mature and purer insulin producing cells than previous methods and in a lab setting the cells were able to secrete insulin and responded strongly to glucose. SANA Biotechnology and the Mayo Clinic announced a strategic collaboration to accelerate development and delivery of Sana's investigational modified pancreatic islet cell therapy for type 1. This is technically called SC451. Initial work will standardize handling, surgical technique, trial design and post treatment care clinical trials. Target date later this year Modular Medical gets FDA clearance for its Pivot, a tubeless patch pump. The pump requires no battery recharging. The company says it has removability for showering sports or discretion. Its quick bolus button enables insulin delivery without a separate controller and San Diego based Modular Medical says this targets almost pumpers who are currently on multiple daily injections. The company's founder, Paul Diperna previously founded Tandem Diabetes and Diperna invented and designed the T SLIM pump from Tandem. The company expects to begin initial shipments by the end of the second quarter of this year. It targets European approval in the fourth quarter of this year as well. Vicentra says it's Kaleido automated insulin pump will be immediately available with no waiting period to get started. Kaleido is a very small, almost miniature patch style insulin pump currently available in Germany, the Netherlands and France. You may have seen this. It's very eye catching. It has customizable aluminum shells in 10 color options. It uses the Diabloup aid algorithm and Dexcom CGMs. The company has targeted late 2026 or 2027 for a US launch. Lilly starts to look for type 2 approval for its newly approved oral obesity pill. New study shows Foundeo was not inferior to long acting insulin when it comes to lowering the risk of major heart problems. The company will submit an application by the end of the second quarter. New study reveals that popular diabetes and weight loss drugs like Ozempic and Wegovy may not work as effectively for about 10% of people due to specific genetic variants. These individuals appear to have a condition called GLP1 resistance where their bodies produce higher levels of the hormone targeted by these drugs but don't respond to it properly. The study published in Genome Medicine focused on how these drugs affect blood sugar. For now, the biological cause of GLP1 resistance remains unclear and is likely influenced by multiple factors Follow up on a story we've been following for a while now. The International Diabetes Federation officially recognized a fifth form of diabetes last year. It is now urging other health authorities like the World Health Organization to do the same. Type 5 diabetes is rarely discussed or researched, and yet it is thought to impact up to 25 million people around the world, especially those in low and middle income nations. Type 5 diabetes seems to stem from nutrient deficiency and is commonly misdiagnosed as other types. And yet, because insulin resistance does not seem to be the primary cause of type 5 diabetes, existing treatments don't help and they may even do harm. Right back to the news in just a minute, where we'll be talking about which is better exercise in the morning or the evening when you have diabetes? Apparently there is a real answer to this a big win for kids with Type one in a big state, and great recognition for a tireless diabetes advocate who found out he had Type 1 when he was acting in the Lion King. It's all right after this. From the very beginning, they mean everything to you, and that means you'd do anything for them, especially if they're at risk. So when it comes to type 1 diabetes, screen it like you mean it. Even if just one person in your family has type one, you're up to 15 times more likely to get it too. Screen it like you mean it, because one blood test could help you spot type 1 long before you need insulin. Talk to your doctor about how to screen for type 1 diabetes, because the more you know, the more you can do. So don't wait. Visit screenfortype1.com to learn more. Again, that's screenfortype1.com right back to the news now. And A big win for students with diabetes in Virginia schools Effective July 1, the Virginia governor signed two bills into law, strengthening and modernizing laws that were more than 25 years old to better support students with diabetes in schools. A few of the updates include Nurses and trained staff can now assist with insertion of insulin pumps and parts. It prevents school divisions from blocking willing and trained staff from providing care. It provides annual information to parents about type 1 and type 2 diabetes and requires the development and implementation of Diabetes plans. Hat Tip 2 Follow T1D's grassroots group for their tireless work on this bill over the past two years. When people exercise may matter just as much as whether they exercise at all. Particularly for people with type 2, exercising in the afternoon or evening produced substantial and enduring improvements in blood sugar regulation, and working out in the morning frequently resulted in higher blood sugar levels and diminished insulin responses. The dawn phenomenon is likely to blame here. That's when cortisol levels surge upon waking and the liver is also triggered to release stored glucose. Despite these findings, the researchers say physical activity at any hour is better than doing nothing, so the best time to exercise is whenever you can manage it. Nice write up for Kyler Cairs in New Orleans Biggest Paper Kyle Banks has been on the show before. He was a Broadway actor performing in the Lion King when he was diagnosed with Type one. He of course continued to act on Broadway and elsewhere, and he has since started his foundation to help get grants for diabetes technology for kids and provide social connections for families. He's developed partnerships with schools and clinics in New Orleans and New York City. And that is it for in the news. If you like what you heard, please consider leaving a review in whatever podcast app you are listening to this on or send the show to somebody you think would appreciate it. We'll be back next week with a long format interview episode and watch for some bonus episodes coming in. We've got some technology to update you on that I don't want to sit on and as we get closer to the summer conferences, boy, there's going to be a lot of news out there. Thanks to my editor John Buchenis from Audio Editing Solutions and thank you so much for listening. I'm Stacey Sims. I'll see you back here soon. Until then, be kind to yourself. Diabetes Connections is a production of Stacy Sims Media. All rights reserved.
B
All wrongs avenged.
A
At one of our recent Mom's Night out events, the Omnipod team was on site asking moms about their experience with the OmniPod 5 automated insulin delivery system. It was so much fun and it was great to hear what the moms have to say. Here's what Angela, mom to Dominic, told us.
B
My son is 10 years old and he uses an Omnipod 5. It's the only pump he has used since he was diagnosed. It's been a life changing piece of equipment for him have he's a competitive swimmer, he is able to keep it on in the pool and we don't have to worry about disconnecting. So we absolutely love Omnipod and it has really just made a big difference in his life.
A
Want to try Omnipod 5 for yourself? Request a free Omnipod 5 starter kit today by visiting omnipod.com diabetesconnections Terms and conditions apply. Eligibility may vary.
Episode: In the News – Stem Cell Research Updates, New Patch Pump Approved, GLP-1 Resistance Studied, Big Win for T1D School Kids, and More!
Date: April 21, 2026
In this special “In the News” edition, Stacey Simms brings listeners the top updates and breakthroughs from the diabetes world. The episode covers advances in stem cell research, recent FDA clearances for diabetes tech, surprising findings about GLP-1 drug resistance, crucial policy wins for T1D students, and more. Tailored for parents, adults with type 1, and anyone interested in the latest diabetes news, Stacey delivers timely and practical information with her signature warmth and directness.
[02:02]
Stacey Simms [02:30]:
“The optimized production process yields more mature and purer insulin producing cells than previous methods... they were able to secrete insulin and responded strongly to glucose.”
[03:12]
[04:23]
Stacey Simms [04:51]:
“For now, the biological cause of GLP1 resistance remains unclear and is likely influenced by multiple factors.”
[05:13]
[07:16]
Stacey Simms [07:36]:
“A big win for students with diabetes in Virginia schools… hats off to Follow T1D’s grassroots group for their tireless work.”
[08:03]
Stacey Simms [08:26]:
“Physical activity at any hour is better than doing nothing, so the best time to exercise is whenever you can manage it.”
[08:40]
On stem cell research:
“These cells… can reverse diabetes in mice.” (Stacey Simms, [02:15])
On new tech:
“Its quick bolus button enables insulin delivery without a separate controller.” (Stacey Simms on Modular Medical’s Pivot, [03:35])
On GLP-1 resistance:
“These individuals appear to have a condition called GLP-1 resistance where their bodies produce higher levels… but don’t respond to it properly.” (Stacey Simms, [04:33])
On Virginia’s school law changes:
“It provides annual information to parents about type 1 and type 2 diabetes and requires the development and implementation of diabetes plans.” (Stacey Simms, [07:27])
On exercise timing:
“When people exercise may matter just as much as whether they exercise at all.” (Stacey Simms, [08:03])
Stacey delivers the news in her usual down-to-earth, informative, and community-focused style. She balances scientific advances and policy wins with practical advice and moments of empathy for those living with or caring for someone with type 1 diabetes.
“If you like what you heard, please consider leaving a review… or send the show to somebody you think would appreciate it.” (Stacey Simms, [09:06])
For in-depth sources, transcripts, and future event info:
Visit diabetes-connections.com.
End of Summary